scispace - formally typeset
L

Lixin Dai

Researcher at Johns Hopkins University School of Medicine

Publications -  19
Citations -  2536

Lixin Dai is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Group I catalytic intron & RNA splicing. The author has an hindex of 16, co-authored 19 publications receiving 2203 citations. Previous affiliations of Lixin Dai include University of Calgary & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences

TL;DR: Tumour microvesicles contain a repertoire of genetic information available for horizontal gene transfer and potential use as blood biomarkers for cancer, including elevated levels of specific coding and non-coding RNA and DNA, mutated and amplified oncogene sequences and transposable elements.
Journal ArticleDOI

Affinity proteomics reveals human host factors implicated in discrete stages of LINE-1 retrotransposition.

TL;DR: A system to express and purify highly active L1 RNP complexes from human suspension cell culture and characterize the copurified proteome is described, identifying 37 high-confidence candidate interactors and suggesting existence of at least three types of compositionally and functionally distinct L1 RNPs.
Journal ArticleDOI

Tropism switching in Bordetella bacteriophage defines a family of diversity-generating retroelements

TL;DR: It is proposed that a TR reverse transcript is mutagenized, integrated into VR as a single non-coding strand, and then partially converted to the parental VR sequence, which allows the diversity-generating system to minimize variability to the subset of bases under selection.
Journal ArticleDOI

Compilation and analysis of group II intron insertions in bacterial genomes: evidence for retroelement behavior

TL;DR: It is suggested that group II introns in bacteria behave primarily as retroelements rather than as introns, and that the strategy for group II introns survival in bacteria is fundamentally different from intron survival in organelles.